The Two Onc Docs, Drs. Samantha Armstrong and Karine Tawagi, provide updated commentary on some the sessions and data of note from the ESMO Congress 2024.
Included in their round-up are in-depth discussion of STAMPEDE, SunRISe-4, and SUNNIFORECAST trials.
1:09-2:40 NIAGRA